交易 Biodesix, Inc. - BDSX CFD
加入收藏夹- 概括
- 历史数据
- 活动
- 收入报表
- 资产负债表
- 现金流
- 所有权
交易条件
价差 | 0.0254 | ||||||||
多头隔夜费
Long position overnight fee
前往平台 | -0.024068% | ||||||||
空头隔夜费
Short position overnight fee
前往平台 | 0.001846% | ||||||||
隔夜费时间 | 21:00 (UTC) | ||||||||
最小交易量 | 1 | ||||||||
货币 | USD | ||||||||
保证金 | 20% | ||||||||
上市交易所 | United States of America | ||||||||
交易费 | 0% |
*Information provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | 平倉 | Change | Change (%) | 開倉 | High | Low |
---|---|---|---|---|---|---|
Mar 24, 2023 | 1.7073 | 0.0800 | 4.92% | 1.6273 | 1.7073 | 1.6273 |
Mar 23, 2023 | 1.6174 | -0.2596 | -13.83% | 1.8770 | 1.8770 | 1.6074 |
Mar 22, 2023 | 1.8570 | 0.0799 | 4.50% | 1.7771 | 1.8969 | 1.7472 |
Mar 21, 2023 | 1.7771 | 0.0300 | 1.72% | 1.7471 | 1.7871 | 1.7372 |
Mar 20, 2023 | 1.7172 | -0.0399 | -2.27% | 1.7571 | 1.7771 | 1.6173 |
Mar 17, 2023 | 1.7571 | -0.0300 | -1.68% | 1.7871 | 1.8670 | 1.7472 |
Mar 16, 2023 | 1.7871 | -0.0799 | -4.28% | 1.8670 | 1.9070 | 1.7172 |
Mar 15, 2023 | 1.8770 | 0.2896 | 18.24% | 1.5874 | 1.8870 | 1.5874 |
Mar 14, 2023 | 1.6373 | -0.0100 | -0.61% | 1.6473 | 1.6973 | 1.6274 |
Mar 13, 2023 | 1.6473 | 0.1498 | 10.00% | 1.4975 | 1.7172 | 1.4975 |
Mar 10, 2023 | 1.5675 | 0.1398 | 9.79% | 1.4277 | 1.6573 | 1.3877 |
Mar 9, 2023 | 1.4776 | -0.2096 | -12.42% | 1.6872 | 1.6873 | 1.4676 |
Mar 8, 2023 | 1.6673 | -0.0898 | -5.11% | 1.7571 | 1.7971 | 1.6673 |
Mar 7, 2023 | 1.7771 | 0.0599 | 3.49% | 1.7172 | 1.7971 | 1.7172 |
Mar 6, 2023 | 1.7572 | -0.3194 | -15.38% | 2.0766 | 2.1366 | 1.7172 |
Mar 3, 2023 | 1.9668 | 0.0000 | 0.00% | 1.9668 | 2.0467 | 1.9668 |
Mar 2, 2023 | 1.9668 | -0.0300 | -1.50% | 1.9968 | 2.0368 | 1.9569 |
Mar 1, 2023 | 1.9868 | -0.0399 | -1.97% | 2.0267 | 2.0467 | 1.9369 |
Feb 28, 2023 | 2.0168 | -0.0299 | -1.46% | 2.0467 | 2.1666 | 2.0068 |
Feb 27, 2023 | 2.0367 | -0.1398 | -6.42% | 2.1765 | 2.2264 | 1.9568 |
Biodesix, Inc. Events
時間(協調世界時) (UTC) | 國家 | 事件 |
---|---|---|
No events scheduled |
- 年度
- 每季度
2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|
总收入 | 54.506 | 45.557 | 24.552 | 20.432 |
收入 | 54.506 | 45.557 | 24.552 | 20.432 |
收入成本,共计 | 30.518 | 21.998 | 6.074 | 4.406 |
毛利 | 23.988 | 23.559 | 18.478 | 16.026 |
总营业费用 | 93.148 | 68.491 | 51.293 | 44.095 |
销售/一般/行政费用,总计 | 47.958 | 32.328 | 30.637 | 25.899 |
研究与开发 | 12.789 | 10.818 | 10.468 | 8.188 |
异常费用(收入) | -0.676 | 0.818 | 4.114 | 5.602 |
营业收入 | -38.642 | -22.934 | -26.741 | -23.663 |
利息收入(费用),非经营净值 | -4.508 | -7.586 | -2.953 | -2.892 |
其他,净值 | -0.009 | -0.83 | -1.032 | 0.389 |
税前净收入 | -43.159 | -31.35 | -30.726 | -26.166 |
税后净收入 | -43.159 | -31.35 | -30.726 | -26.166 |
未计算非常项目前的净收益 | -43.159 | -31.35 | -30.726 | -26.166 |
净收入 | -43.159 | -31.35 | -30.726 | -26.166 |
普通股股东可获收益 (不含非经常性项目) | -43.159 | -31.35 | -30.726 | -26.166 |
普通股股东可获收益 (含非經常性項目) | -43.159 | -31.35 | -30.726 | -26.166 |
摊薄净收入 | -43.159 | -31.35 | -30.726 | -26.166 |
摊薄后加权平均股 | 27.365 | 26.5615 | 26.2541 | 26.2541 |
扣除特别项目的每股摊薄盈利 | -1.57716 | -1.18028 | -1.17033 | -0.99665 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | ||
每股正常摊薄盈利 | -1.60186 | -1.14948 | -1.01363 | -0.78327 |
Depreciation / Amortization | 2.559 | 2.529 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
总收入 | 6.548 | 7.224 | 6.531 | 11.885 | 28.866 |
收入 | 6.548 | 7.224 | 6.531 | 11.885 | 28.866 |
收入成本,共计 | 3.235 | 2.493 | 2.722 | 7.085 | 18.218 |
毛利 | 3.313 | 4.731 | 3.809 | 4.8 | 10.648 |
总营业费用 | 21.009 | 19 | 16.499 | 22.472 | 35.177 |
销售/一般/行政费用,总计 | 14.487 | 13.558 | 13.607 | 11.425 | 11.927 |
研究与开发 | 3.206 | 2.852 | 3.293 | 3.323 | 3.321 |
异常费用(收入) | 0.081 | 0.097 | -3.123 | 0.639 | 1.711 |
营业收入 | -14.461 | -11.776 | -9.968 | -10.587 | -6.311 |
利息收入(费用),非经营净值 | -1.137 | -1.496 | -1.546 | -0.815 | -0.651 |
其他,净值 | 0.012 | -0.01 | 0 | 0 | 0.001 |
税前净收入 | -15.586 | -13.282 | -11.514 | -11.402 | -6.961 |
税后净收入 | -15.586 | -13.282 | -11.514 | -11.402 | -6.961 |
未计算非常项目前的净收益 | -15.586 | -13.282 | -11.514 | -11.402 | -6.961 |
净收入 | -15.586 | -13.282 | -11.514 | -11.402 | -6.961 |
普通股股东可获收益 (不含非经常性项目) | -15.586 | -13.282 | -11.514 | -11.402 | -6.961 |
普通股股东可获收益 (含非經常性項目) | -15.586 | -13.282 | -11.514 | -11.402 | -6.961 |
摊薄净收入 | -15.586 | -13.282 | -11.514 | -11.402 | -6.961 |
摊薄后加权平均股 | 31.07 | 27.059 | 28.051 | 27.73 | 26.604 |
扣除特别项目的每股摊薄盈利 | -0.50164 | -0.49085 | -0.41047 | -0.41118 | -0.26165 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常摊薄盈利 | -0.49903 | -0.48727 | -0.5218 | -0.38814 | -0.19734 |
- 年度
- 每季度
2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|
流动资产总额 | 43.613 | 86.14 | 12.7 | 9.913 |
现金和短期投资 | 32.712 | 62.126 | 5.286 | 5.914 |
现金等价物 | 32.712 | 62.126 | 5.286 | 5.914 |
应收账款总额,净额 | 3.656 | 15.304 | 5.292 | 1.892 |
Accounts Receivable - Trade, Net | 3.656 | 15.304 | 5.292 | 1.892 |
Other Current Assets, Total | 7.245 | 8.71 | 2.122 | 2.107 |
Total Assets | 76.097 | 121.07 | 41.633 | 39.057 |
Property/Plant/Equipment, Total - Net | 4.179 | 3.178 | 2.12 | 1.388 |
Property/Plant/Equipment, Total - Gross | 10.928 | 9.902 | 8.506 | 6.956 |
Accumulated Depreciation, Total | -6.749 | -6.724 | -6.386 | -5.568 |
Goodwill, Net | 15.031 | 15.031 | 11.631 | 10.804 |
Intangibles, Net | 11.617 | 13.26 | 15.092 | 16.852 |
Other Long Term Assets, Total | 1.657 | 3.461 | 0.09 | 0.1 |
Total Current Liabilities | 28.96 | 32.125 | 22.6 | 4.468 |
Accounts Payable | 1.662 | 8.964 | 1.717 | 0.886 |
Accrued Expenses | 4.899 | 4.69 | 1.899 | 1.568 |
Notes Payable/Short Term Debt | 0 | 0 | 12.045 | 0 |
Other Current Liabilities, Total | 22.38 | 6.631 | 6.939 | 2.014 |
Total Liabilities | 56.37 | 79.904 | 76.213 | 53.125 |
Total Long Term Debt | 9.993 | 15.926 | 23.812 | 23.099 |
Long Term Debt | 9.993 | 15.926 | 23.812 | 23.099 |
Other Liabilities, Total | 17.417 | 31.853 | 29.801 | 25.558 |
Total Equity | 19.727 | 41.166 | -34.58 | -14.068 |
Redeemable Preferred Stock | 0 | 0 | 193.959 | 183.962 |
Common Stock | 0.031 | 0.027 | 0.001 | 0.001 |
Additional Paid-In Capital | 321.669 | 299.953 | 2.324 | 2.107 |
Retained Earnings (Accumulated Deficit) | -301.973 | -258.814 | -230.864 | -200.138 |
Total Liabilities & Shareholders’ Equity | 76.097 | 121.07 | 41.633 | 39.057 |
Total Common Shares Outstanding | 30.7896 | 26.5615 | 26.2541 | 26.2541 |
Current Port. of LT Debt/Capital Leases | 0.019 | 11.84 | 0 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
流动资产总额 | 27.233 | 43.613 | 56.445 | 68.45 | 81.244 |
现金和短期投资 | 16.427 | 32.712 | 47.913 | 56.349 | 55.329 |
现金等价物 | 16.427 | 32.712 | 47.913 | 56.349 | 55.329 |
应收账款总额,净额 | 3.774 | 3.656 | 2.784 | 5.281 | 18.367 |
Accounts Receivable - Trade, Net | 3.774 | 3.656 | 2.784 | 5.281 | 18.367 |
Other Current Assets, Total | 7.032 | 7.245 | 5.748 | 6.82 | 7.548 |
Total Assets | 61.651 | 76.097 | 89.997 | 101.804 | 115.486 |
Property/Plant/Equipment, Total - Net | 6.247 | 4.179 | 4.432 | 3.378 | 3.387 |
Property/Plant/Equipment, Total - Gross | 13.409 | 10.928 | 11.827 | 10.471 | 10.369 |
Accumulated Depreciation, Total | -7.162 | -6.749 | -7.395 | -7.093 | -6.982 |
Goodwill, Net | 15.031 | 15.031 | 15.031 | 15.031 | 15.031 |
Intangibles, Net | 11.131 | 11.617 | 11.992 | 12.4 | 12.821 |
Other Long Term Assets, Total | 2.009 | 1.657 | 2.097 | 2.545 | 3.003 |
Total Current Liabilities | 29.811 | 28.96 | 22.787 | 21.272 | 16.124 |
Accounts Payable | 2.12 | 1.662 | 1.6 | 1.16 | 3.747 |
Accrued Expenses | 4.597 | 4.899 | 3.533 | 2.959 | 2.622 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 0.051 | 0.019 | 0.02 | 3.106 | 2.707 |
Other Current Liabilities, Total | 23.043 | 22.38 | 17.634 | 14.047 | 7.048 |
Total Liabilities | 53.87 | 56.37 | 73.964 | 76.031 | 79.054 |
Total Long Term Debt | 10.055 | 9.993 | 29.975 | 29.955 | 30.328 |
Long Term Debt | 10.055 | 9.993 | 29.975 | 29.955 | 30.328 |
Other Liabilities, Total | 14.004 | 17.417 | 21.202 | 24.804 | 32.602 |
Total Equity | 7.781 | 19.727 | 16.033 | 25.773 | 36.432 |
Redeemable Preferred Stock | 0 | 0 | 0 | 0 | |
Common Stock | 0.032 | 0.031 | 0.027 | 0.027 | 0.027 |
Additional Paid-In Capital | 325.308 | 321.669 | 304.697 | 302.923 | 302.18 |
Retained Earnings (Accumulated Deficit) | -317.559 | -301.973 | -288.691 | -277.177 | -265.775 |
Total Liabilities & Shareholders’ Equity | 61.651 | 76.097 | 89.997 | 101.804 | 115.486 |
Total Common Shares Outstanding | 31.8893 | 30.7896 | 27.0201 | 26.9489 | 26.7854 |
- 年度
- 每季度
2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|
净收入/起跑线 | -43.159 | -31.35 | -30.726 | -26.166 |
经营活动产生的现金 | -28.223 | -21.366 | -21.726 | -17.677 |
经营活动产生的现金 | 3.178 | 2.903 | 2.793 | 1.74 |
非现金物品 | 7.167 | 11.882 | 7.852 | 6.496 |
营运资金的变化 | 4.591 | -4.801 | -1.645 | 0.253 |
投资活动产生的现金 | -2.547 | -2.927 | -1.872 | -0.617 |
资本支出 | -2.547 | -2.177 | -1.416 | -0.617 |
其他投资现金流量项目,总计 | 0 | -0.75 | -0.456 | 0 |
融资活动产生的现金 | 1.262 | 81.131 | 22.972 | 19.032 |
融资现金流项目 | -0.5 | -8.249 | -0.119 | -0.283 |
股票的发行(报废),净额 | 17.112 | 73.34 | 10.047 | 8.55 |
债务的发行(退还),净额 | -15.35 | 16.04 | 13.044 | 10.765 |
现金净变化 | -29.508 | 56.838 | -0.626 | 0.738 |
已付现金利息 | 1.676 | 1.844 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | -15.586 | -43.159 | -29.877 | -18.363 | -6.961 |
Cash From Operating Activities | -13.099 | -28.223 | -18.026 | -10.236 | -11.326 |
Cash From Operating Activities | 0.908 | 3.178 | 2.323 | 1.523 | 0.746 |
Non-Cash Items | 2.674 | 7.167 | 4.704 | 5.336 | 3.721 |
Changes in Working Capital | -1.095 | 4.591 | 4.824 | 1.268 | -8.832 |
Cash From Investing Activities | -0.352 | -2.547 | -1.906 | -0.864 | -0.516 |
Capital Expenditures | -0.352 | -2.547 | -1.906 | -0.864 | -0.516 |
Other Investing Cash Flow Items, Total | 0 | 0 | 0 | 0 | |
Cash From Financing Activities | -2.834 | 1.262 | 5.625 | 5.229 | 4.951 |
Financing Cash Flow Items | -4.6 | -0.5 | 0.232 | -0.109 | -0.108 |
Issuance (Retirement) of Stock, Net | 1.674 | 17.112 | 0.739 | 0.679 | 0.475 |
Issuance (Retirement) of Debt, Net | 0.092 | -15.35 | 4.654 | 4.659 | 4.584 |
Net Change in Cash | -16.285 | -29.508 | -14.307 | -5.871 | -6.891 |
Cash Interest Paid | 0.223 |
投资者名称 | 投资者类型 | 流通股百分比 | 持有股份 | 股份变动 | 持有日期 | 换手率 |
---|---|---|---|---|---|---|
Schuler (Jack W) | Individual Investor | 25.5879 | 19952112 | 8695652 | 2022-11-21 | |
Kennedy (Lawrence T Jr.) | Individual Investor | 19.0156 | 14827404 | 0 | 2023-01-03 | MED |
Patience (John) | Individual Investor | 9.0025 | 7019695 | 1739130 | 2022-11-21 | LOW |
Birchview Capital, LP | Investment Advisor | 6.4632 | 5039633 | 2884624 | 2022-12-31 | LOW |
AIGH Capital Management, LLC. | Private Equity | 5.8936 | 4595512 | -973389 | 2022-12-31 | MED |
Cawthorn (Robert E) | Individual Investor | 4.6838 | 3652220 | 1723341 | 2022-11-21 | LOW |
Strobeck (Matthew W) | Individual Investor | 3.7251 | 2904668 | 1304345 | 2022-11-21 | LOW |
Industrial Development Funding LLC | Corporation | 2.432 | 1896374 | 0 | 2022-03-01 | LOW |
Worth Venture Partners, LLC | Investment Advisor/Hedge Fund | 1.9211 | 1497963 | 1497963 | 2022-12-31 | HIGH |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 1.4189 | 1106403 | 866747 | 2022-12-31 | LOW |
Wells Fargo Advisors | Research Firm | 0.9923 | 773725 | 5000 | 2022-12-31 | LOW |
Essex Investment Management Company, LLC | Investment Advisor/Hedge Fund | 0.4848 | 377994 | -29 | 2022-12-31 | LOW |
Life Sciences Alternative Financing, L.L.C. | Corporation | 0.3771 | 294053 | 0 | 2022-03-01 | LOW |
Cannell & Co. | Investment Advisor | 0.2637 | 205605 | 0 | 2022-12-31 | LOW |
Hutton Scott | Individual Investor | 0.2561 | 199726 | 28499 | 2023-02-09 | HIGH |
Massarany (Hany) | Individual Investor | 0.1769 | 137934 | 130434 | 2022-11-21 | HIGH |
Hightower Advisors, LLC | Investment Advisor | 0.175 | 136434 | 136434 | 2022-12-31 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.1617 | 126122 | 2052 | 2022-12-31 | LOW |
Endurant Capital Management LP | Hedge Fund | 0.1596 | 124430 | -5706 | 2022-12-31 | HIGH |
Millennium Management LLC | Hedge Fund | 0.1382 | 107788 | -10260 | 2022-12-31 | HIGH |
交易計算器
如果您在特定日期(选择一个日期)开立差价合约交易并在不同日期(选择一个日期)关闭交易,计算您的假设盈亏。
貿易佣金
0
- 1:1
杠杆
1:1
- 20
- 100
- 500
- 1000
- 10000
投資
交易規模(槓桿 x 投資):
開倉
平倉
做空 做多
Biodesix, Inc. Company profile
关于 Biodesix Inc.
Biodesix, Inc.是一家总部设在美国的公司,从事肿瘤学血液诊断测试的开发和商业化。 公司的产品Biodesix Lung Reflex整合了基因组学和蛋白质组学的血液结果,揭示了肺癌的两面性。 其GeneStrat测试为非小细胞肺癌(NSCLC)患者在72小时内提供基于血液的突变结果。 它的VeriStrat测试为估计肾小球滤过率(EGFR)突变(EGFR野生型)检测阴性或EGFR突变状态未知的(NSCLC)患者提供基于血液的预测性和预后性蛋白质组学信息。
Industry: | Medical & Diagnostic Laboratories |
Suite 100
2970 Wilderness Place
BOULDER
COLORADO 80301
US
收入报表
- Annual
- Quarterly
人们也观看
还在找一位您可以信任的经纪商吗?
加入成为全球500,000万多名交易者的一份子,选择利用Capital.com进行交易吧。